SNDX Dividend: Syndax Pharmaceuticals Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	78	23	0	0	139	1
Revenue Growth (YoY)	2,500%	--	--	-100%	13,800%	0%
Cost of Revenue	3	0	--	--	--	--
Gross Profit	62	22	--	--	--	--
Selling, General & Admin	154	120	66	33	25	22
Research & Development	260	241	163	118	88	50
Operating Expenses	414	362	229	151	113	72
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-335	-318	-209	-149	24	-73
Income Tax Expense	--	--	--	--	--	--
Net Income	-335	-318	-209	-149	24	-77
Net Income Growth	27%	52%	40%	-721%	-131%	38%
Shares Outstanding (Diluted)	86	85.62	70.37	60.8	53.6	41.3
Shares Change (YoY)	1%	22%	16%	13%	30%	35%
EPS (Diluted)	-3.88	-3.72	-2.97	-2.46	0.46	-1.87
EPS Growth	25%	25%	21%	-635%	-125%	2%
Free Cash Flow	-303	-274	-160	-133	29	-71
Free Cash Flow Per Share	-3.52	-3.2	-2.27	-2.18	0.54	-1.71
Gross Margin	79.48%	95.65%	--	--	--	--
Operating Margin	-434.61%	-1,473.91%	0%	0%	18.7%	-7,100%
Profit Margin	-429.48%	-1,382.6%	0%	0%	17.26%	-7,700%
Free Cash Flow Margin	-388.46%	-1,191.3%	0%	0%	20.86%	-7,100%
EBITDA	-339	-339	-229	-151	26	-71
EBITDA Margin	-434.61%	-1,473.91%	0%	0%	18.7%	-7,100%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-339	-339	-229	-151	26	-71
EBIT Margin	-434.61%	-1,473.91%	0%	0%	18.7%	-7,100%
Effective Tax Rate	--	--	--	--	--	--

Syndax Pharmaceuticals Inc (SNDX) Price